Proteins / PGPEP1L

DarkA6NFU8 · Homo sapiens (Human) · 196 aa

PGPEP1L

Pyroglutamyl-peptidase 1-like protein

AI prediction, not experimentally verified. The function, GO terms and reasoning are generated by a model (BioReason-Pro). Treat them as a hypothesis to test, not as a fact.

Predicted 3D structure

AlphaFold model.

In plain language

PGPEP1L has barely been studied. The model's best guess: A soluble cytosolic metalloprotease that removes N-terminal pyroglutamate from intracellular peptides, thereby unblocking their N-termini and feeding them back into general peptide turnover. By catalyzing this key terminal step in peptide maturation and clearance, it sustains intracellular proteolysis and amino acid economy within the cytoplasm.

Predicted function

A soluble cytosolic metalloprotease that removes N-terminal pyroglutamate from intracellular peptides, thereby unblocking their N-termini and feeding them back into general peptide turnover.

Confidence: the model gives no confidence score, and this protein has no known function to compare with. Treat it as a hypothesis.

Sequence · 196 aa · coloured by model confidence
1MKPRTLVELS11KLGLGNETVV21QLRTLELPVD31YREAKRRVTG41IWEDHQPQLV51VHVGMDTAAK61AIILEQSGKN71QGYRDADIRS81FWPEGGVCLP91GSPDVLESGV101CMKAVCKRVA111VEGVDVIFSR121DAGRYVCDYT131YYLSLHHGKG141CAALIHVPPL151SRGLPASLLG161RALRVIIQEM171LEEVGKPKHR181AQFEENSTMV191LPAKGN

Protein domains

Known building blocks found by InterPro, placed along the 196 amino acids of the chain. Hover or tap a block for details.

150100150196

Predicted function

Model summary

A soluble cytosolic metalloprotease that removes N-terminal pyroglutamate from intracellular peptides, thereby unblocking their N-termini and feeding them back into general peptide turnover. By catalyzing this key terminal step in peptide maturation and clearance, it sustains intracellular proteolysis and amino acid economy within the cytoplasm. Its soluble architecture and transient macromolecular contacts position it as a central node in cytosolic peptide-processing pathways.

Predicted Gene Ontology terms

Molecular function

What it does chemically

Biological process

Which larger process it takes part in

Cellular component

Where in the cell it sits

Model reasoning

How the model got to its answer

  1. 01

    I begin with the InterPro architecture.

    The sequence is dominated by IPR036440 (Peptidase C15, pyroglutamyl peptidase I-like superfamily, residues 4–184), within which sits IPR016125 (Peptidase C15, pyroglutamyl peptidase I-like family, residues 8–172). This nested arrangement—an explicit C15 peptidase family core embedded in its broader superfamily—defines a cytosolic C15 metalloprotease fold specialized for removing N-terminal pyroglutamate (5-oxoproline) from peptides. The C15 architecture dictates a metalloprotease active site that hydrolyzes the peptide bond immediately after a blocked N-terminus, thereby unmasking a free amino group and terminating the inhibitory pyroglutamyl cap.

  2. 02

    This domain architecture causally specifies molecular function.

    The C15 peptidase scaffold creates a catalytic pocket that accommodates N-terminally blocked substrates and catalyzes hydrolysis; this is the biochemical essence of proteolysis. Such enzymes often rely on transient macromolecular contacts to position substrates and assemble with cellular partners, which supports GO:0005515 protein binding as an auxiliary function. The catalytic role directly drives GO:0006508 proteolysis by converting otherwise refractory pyroglutamylated peptides into processable intermediates.

  3. 03

    From function to process, removal of N-terminal pyroglutamate is a decisive step in peptide turnover and maturation pathways.

    By stripping the pyroglutamyl cap, the enzyme feeds peptides back into general proteolytic routes, coupling cytosolic peptide clearance to broader amino acid and peptide homeostasis. This mechanistic coupling explains its central role in intracellular peptide processing.

  4. 04

    Cellular location follows from both the soluble C15 fold and the absence of transmembrane or secretion signals.

    The enzyme operates as a soluble protease in the cytoplasm, with its steady-state pool concentrated in the aqueous phase of the cytoplasm. This supports localization to the cytoplasm and more specifically the GO:0005829 cytosol, consistent with a soluble metalloprotease that surveys cytosolic peptide pools.

  5. 05

    Mechanistically, the enzyme likely recognizes the pyroglutamyl ring via a stereoselective binding groove and uses a metal-activated water molecule for nucleophilic attack at the peptide’s N-terminal bond.

    Substrate selection is enforced by a pocket that tolerates the cyclic pG cap and adjacent residues, ensuring efficient trimming of blocked peptides. In this cytosolic context, plausible interaction partners include peptide-generating systems and downstream peptidases that hand off substrates after cap removal. I hypothesize transient assemblies with cytosolic peptidyl-dipeptidases and amino acid–producing enzymes to channel products efficiently and prevent accumulation of refractory pyroglutamylated intermediates.

Technical details

InterPro entries

  • IPR036440 Peptidase C15, pyroglutamyl peptidase I-like superfamily homologous superfamily · 4–184
  • IPR016125 Peptidase C15, pyroglutamyl peptidase I-like family · 8–172

Sources

Method

BioReason-Pro with the ESM3 protein language model (esm3-sm-open-v1). How the atlas is made →

API

/api/v1/proteins/A6NFU8 · API docs